Global Cancer Medication Market Growth, Trends, and Forecasts 2016-2026

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 Market Overview

2.1.1 Global Cancer Medication Market Size and Forecast, 2016-2026

2.1.2 Cancer Medication Market Size and Forecast by Region, 2016 VS 2021 VS 2026

2.2 Global Cancer Medication Market Size and Forecast by Regions, 2016-2026 ($ millions)

2.3 Americas Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)

2.4 APAC Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)

2.5 Europe Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)

2.6 MENA Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)

3 Cancer Medication Market Size by Player

3.1 Global Cancer Medication Market Size by Player

3.1.1 Global Top Players Cancer Medication Revenue, 2019-2021E ($ millions)

3.1.2 Global Top Cancer Medication Players Market Share, 2019-2021E

3.2 Global Key Cancer Medication Players Rank in 2020

3.3 Global Key Cancer Medication Players Head office and Products Offered

3.4 Market Concentration Rate Analysis

3.4.1 Competition Landscape Analysis

3.4.2 Concentration Ratio (CR3, CR5 and CR10), 2019-2021E

3.5 New Products and Potential Entrants

3.6 Mergers & Acquisitions, Expansion

4 Cancer Medication Segment by Type

4.1 Overview

4.1.1 Antimetabolite

4.1.2 Alkaloid Drugs

4.1.3 Hormone

4.1.4 Targeted Drug

4.1.5 Platinum-based Drugs

4.1.6 Other

4.2 Global Cancer Medication Market Size by Type, 2016-2026 ($ millions)

4.3 Antimetabolite Market Size by Region, 2016-2026 ($ millions)

4.4 Alkaloid Drugs Market Size by Region, 2016-2026 ($ millions)

4.5 Hormone Market Size by Region, 2016-2026 ($ millions)

4.6 Targeted Drug Market Size by Region, 2016-2026 ($ millions)

4.7 Platinum-based Drugs Market Size by Region, 2016-2026 ($ millions)

4.8 Other Market Size by Region, 2016-2026 ($ millions)

5 Cancer Medication Segment by Application

5.1 Overview

5.1.1 Blood Cancer

5.1.2 Breast Cancer

5.1.3 Castrointestinal Cancer

5.1.4 Prostate Cancer

5.1.5 Respiratory/Lung Cancer

5.1.6 Other

5.2 Global Cancer Medication Market Size and Forecast by Application, 2016-2026

5.3 Blood Cancer Market Size by Region, 2016-2026 ($ millions)

5.4 Breast Cancer Market Size by Region, 2016-2026 ($ millions)

5.5 Castrointestinal Cancer Market Size by Region, 2016-2026 ($ millions)

5.6 Prostate Cancer Market Size by Region, 2016-2026 ($ millions)

5.7 Respiratory/Lung Cancer Market Size by Region, 2016-2026 ($ millions)

5.8 Other Market Size by Region, 2016-2026 ($ millions)

6 Americas

6.1 Americas Cancer Medication Market Size by Country

6.2 United States Cancer Medication Market Size

6.3 Canada Cancer Medication Market Size

6.4 Mexico Cancer Medication Market Size

6.5 Brazil Cancer Medication Market Size

7 APAC

7.1 APAC Cancer Medication Market Size by Region

7.2 China Cancer Medication Market Size

7.3 Japan Cancer Medication Market Size

7.4 Korea Cancer Medication Market Size

7.5 Taiwan Cancer Medication Market Size

7.6 India Cancer Medication Market Size

7.7 Australia Cancer Medication Market Size

7.8 Indonesia Cancer Medication Market Size

7.9 Thailand Cancer Medication Market Size

7.10 Malaysia Cancer Medication Market Size

7.11 Philippines Cancer Medication Market Size

7.12 Vietnam Cancer Medication Market Size

8 Europe

8.1 Europe Cancer Medication Market Size by Country

8.2 Germany Cancer Medication Market Size

8.3 France Cancer Medication Market Size

8.4 UK Cancer Medication Market Size

8.5 Russia Cancer Medication Market Size

8.6 Italy Cancer Medication Market Size

8.7 Australia Cancer Medication Market Size

8.8 Benelux Cancer Medication Market Size

8.9 Nordic Cancer Medication Market Size

9 MENA

9.1 MENA Cancer Medication Market Size by Country

9.2 Saudi Arabia Cancer Medication Market Size

9.3 UAE Cancer Medication Market Size

9.4 Turkey Cancer Medication Market Size

9.5 South Africa Cancer Medication Market Size

9.6 Egypt Cancer Medication Market Size

10 Market Drivers, Challenges and Trends

10.1 Market Drivers and Impact

10.1.1 Growing Demand from Key Regions

10.1.2 Growing Demand from Key Applications and Potential Industries

10.2 Market Challenges and Impact

10.3 Market Trends

11 Key Players Analysis

11.1 Roche

11.1.1 Roche Company Information

11.1.2 Roche Cancer Medication Product Offered

11.1.3 Roche Cancer Medication Revenue and YoY Growth, 2019-2021E

11.1.4 Roche Main Business Overview

11.1.5 Roche Latest Developments

11.2 HENGRUI

11.2.1 HENGRUI Company Information

11.2.2 HENGRUI Cancer Medication Product Offered

11.2.3 HENGRUI Cancer Medication Revenue and YoY Growth, 2019-2021E

11.2.4 HENGRUI Main Business Overview

11.2.5 HENGRUI Latest Developments

11.3 AstraZeneca

11.3.1 AstraZeneca Company Information

11.3.2 AstraZeneca Cancer Medication Product Offered

11.3.3 AstraZeneca Cancer Medication Revenue and YoY Growth, 2019-2021E

11.3.4 AstraZeneca Main Business Overview

11.3.5 AstraZeneca Latest Developments

11.4 QILU

11.4.1 QILU Company Information

11.4.2 QILU Cancer Medication Product Offered

11.4.3 QILU Cancer Medication Revenue and YoY Growth, 2019-2021E

11.4.4 QILU Main Business Overview

11.4.5 QILU Latest Developments

11.5 Sanofi

11.5.1 Sanofi Company Information

11.5.2 Sanofi Cancer Medication Product Offered

11.5.3 Sanofi Cancer Medication Revenue and YoY Growth, 2019-2021E

11.5.4 Sanofi Main Business Overview

11.5.5 Sanofi Latest Developments

11.6 HANSOH

11.6.1 HANSOH Company Information

11.6.2 HANSOH Cancer Medication Product Offered

11.6.3 HANSOH Cancer Medication Revenue and YoY Growth, 2019-2021E

11.6.4 HANSOH Main Business Overview

11.6.5 HANSOH Latest Developments

11.7 LUYE

11.7.1 LUYE Company Information

11.7.2 LUYE Cancer Medication Product Offered

11.7.3 LUYE Cancer Medication Revenue and YoY Growth, 2019-2021E

11.7.4 LUYE Main Business Overview

11.7.5 LUYE Latest Developments

11.8 Novartis

11.8.1 Novartis Company Information

11.8.2 Novartis Cancer Medication Product Offered

11.8.3 Novartis Cancer Medication Revenue and YoY Growth, 2019-2021E

11.8.4 Novartis Main Business Overview

11.8.5 Novartis Latest Developments

11.9 GuiZhou YiBai

11.9.1 GuiZhou YiBai Company Information

11.9.2 GuiZhou YiBai Cancer Medication Product Offered

11.9.3 GuiZhou YiBai Cancer Medication Revenue and YoY Growth, 2019-2021E

11.9.4 GuiZhou YiBai Main Business Overview

11.9.5 GuiZhou YiBai Latest Developments

11.10 Lunan

11.10.1 Lunan Company Information

11.10.2 Lunan Cancer Medication Product Offered

11.10.3 Lunan Cancer Medication Revenue and YoY Growth, 2019-2021E

11.10.4 Lunan Main Business Overview

11.10.5 Lunan Latest Developments

11.11 Eli Lilly and Company

11.11.1 Eli Lilly and Company Company Information

11.11.2 Eli Lilly and Company Cancer Medication Product Offered

11.11.3 Eli Lilly and Company Cancer Medication Revenue and YoY Growth, 2019-2021E

11.11.4 Eli Lilly and Company Main Business Overview

11.11.5 Eli Lilly and Company Latest Developments

12 Research Findings and Conclusion

Table 1. Cancer Medication Market Size CAGR by Region 2020-2026 ($ Millions)

Table 2. Global Cancer Medication Market Size by Regions, 2016-2026 ($ millions)

Table 3. Global Cancer Medication Market Size Share by Regions, 2016-2026

Table 4. Global Cancer Medication Revenue by Player, 2019-2021E ($ millions)

Table 5. Global Cancer Medication Revenue Market Share by Player, 2019-2021E

Table 6. Global Key Cancer Medication Players Rank in 2020, Based on the Revenue in Cancer Medication

Table 7. Global Key Cancer Medication Players Head office and Products Offered

Table 8. Cancer Medication Concentration Ratio (CR3, CR5 and CR10), 2019-2021E

Table 9. New Products and Potential Entrants

Table 10. Mergers & Acquisitions, Expansion

Table 11. Major Players of Antimetabolite

Table 12. Major Players of Alkaloid Drugs

Table 13. Major Players of Hormone

Table 14. Major Players of Targeted Drug

Table 15. Major Players of Platinum-based Drugs

Table 16. Major Players of Other

Table 17. Global Cancer Medication Market Size CAGR by Type ($ millions): 2016 VS 2021 VS 2026

Table 18. Global Cancer Medication Market Size by Type, 2016-2026 ($ millions)

Table 19. Global Cancer Medication Market Size Share by Type, 2016-2026

Table 20. Global Antimetabolite Market Size by Region, 2016-2026 ($ millions)

Table 21. Global Antimetabolite Market Size Share by Region, 2016-2026

Table 22. Global Alkaloid Drugs Market Size by Region, 2016-2026 ($ millions)

Table 23. Global Alkaloid Drugs Market Size Share by Region, 2016-2026

Table 24. Global Hormone Market Size by Region, 2016-2026 ($ millions)

Table 25. Global Hormone Market Size Share by Region, 2016-2026

Table 26. Global Targeted Drug Market Size by Region, 2016-2026 ($ millions)

Table 27. Global Targeted Drug Market Size Share by Region, 2016-2026

Table 28. Global Platinum-based Drugs Market Size by Region, 2016-2026 ($ millions)

Table 29. Global Platinum-based Drugs Market Size Share by Region, 2016-2026

Table 30. Global Other Market Size by Region, 2016-2026 ($ millions)

Table 31. Global Other Market Size Share by Region, 2016-2026

Table 32. Cancer Medication Market Size CAGR by Application ($ millions): 2016 VS 2021 VS 2026

Table 33. Global Cancer Medication Market Size Forecast by Application, 2016-2026 ($ millions)

Table 34. Global Cancer Medication Market Size Share Forecast by Application, 2016-2026

Table 35. Blood Cancer Market Size by Region, 2016-2026 ($ millions)

Table 36. Blood Cancer Market Size Share by Region, 2016-2026

Table 37. Breast Cancer Market Size by Region, 2016-2026 ($ millions)

Table 38. Breast Cancer Market Size Share by Region, 2016-2026

Table 39. Castrointestinal Cancer Market Size by Region, 2016-2026 ($ millions)

Table 40. Castrointestinal Cancer Market Size Share by Region, 2016-2026

Table 41. Prostate Cancer Market Size by Region, 2016-2026 ($ millions)

Table 42. Prostate Cancer Market Size Share by Region, 2016-2026

Table 43. Respiratory/Lung Cancer Market Size by Region, 2016-2026 ($ millions)

Table 44. Respiratory/Lung Cancer Market Size Share by Region, 2016-2026

Table 45. Other Market Size by Region, 2016-2026 ($ millions)

Table 46. Other Market Size Share by Region, 2016-2026

Table 47. Americas Cancer Medication Market Size by Country, 2016-2021 ($ Millions)

Table 48. Americas Cancer Medication Market Size Share by Country, 2016-2021

Table 49. APAC Cancer Medication Market Size by Region, 2016-2021 ($ Millions)

Table 50. APAC Cancer Medication Market Size Share by Region, 2016-2021

Table 51. Europe Cancer Medication Market Size by Country, 2016-2021 ($ Millions)

Table 52. Europe Cancer Medication Market Size Share by Country, 2016-2021

Table 53. MENA Cancer Medication Market Size by Country, 2016-2021 ($ Millions)

Table 54. MENA Cancer Medication Market Size Share by Country, 2016-2021

Table 55. Key and Potential Regions of Cancer Medication

Table 56. Key Application and Potential Industries of Cancer Medication

Table 57. Key Challenges of Cancer Medication

Table 58. Key Trends of Cancer Medication

Table 59. Roche Details, Head Office, Cancer Medication Area Served and Its Competitors

Table 60. Roche Cancer Medication Product Offered

Table 61. Roche Cancer Medication Revenue ($ million) and YoY Growth, 2019-2021E

Table 62. Roche Main Business

Table 63. Roche Latest Developments

Table 64. HENGRUI Details, Head Office, Cancer Medication Area Served and Its Competitors

Table 65. HENGRUI Cancer Medication Product Offered

Table 66. HENGRUI Cancer Medication Revenue ($ million) and YoY Growth, 2019-2021E

Table 67. HENGRUI Main Business

Table 68. HENGRUI Latest Developments

Table 69. AstraZeneca Details, Head Office, Cancer Medication Area Served and Its Competitors

Table 70. AstraZeneca Cancer Medication Product Offered

Table 71. AstraZeneca Cancer Medication Revenue ($ million) and YoY Growth, 2019-2021E

Table 72. AstraZeneca Main Business

Table 73. AstraZeneca Latest Developments

Table 74. QILU Details, Head Office, Cancer Medication Area Served and Its Competitors

Table 75. QILU Cancer Medication Product Offered

Table 76. QILU Cancer Medication Revenue ($ million) and YoY Growth, 2019-2021E

Table 77. QILU Main Business

Table 78. QILU Latest Developments

Table 79. Sanofi Details, Head Office, Cancer Medication Area Served and Its Competitors

Table 80. Sanofi Cancer Medication Product Offered

Table 81. Sanofi Cancer Medication Revenue ($ million) and YoY Growth, 2019-2021E

Table 82. Sanofi Main Business

Table 83. Sanofi Latest Developments

Table 84. HANSOH Details, Head Office, Cancer Medication Area Served and Its Competitors

Table 85. HANSOH Cancer Medication Product Offered

Table 86. HANSOH Cancer Medication Revenue ($ million) and YoY Growth, 2019-2021E

Table 87. HANSOH Main Business

Table 88. HANSOH Latest Developments

Table 89. LUYE Details, Head Office, Cancer Medication Area Served and Its Competitors

Table 90. LUYE Cancer Medication Product Offered

Table 91. LUYE Cancer Medication Revenue ($ million) and YoY Growth, 2019-2021E

Table 92. LUYE Main Business

Table 93. LUYE Latest Developments

Table 94. Novartis Details, Head Office, Cancer Medication Area Served and Its Competitors

Table 95. Novartis Cancer Medication Product Offered

Table 96. Novartis Cancer Medication Revenue ($ million) and YoY Growth, 2019-2021E

Table 97. Novartis Main Business

Table 98. Novartis Latest Developments

Table 99. GuiZhou YiBai Details, Head Office, Cancer Medication Area Served and Its Competitors

Table 100. GuiZhou YiBai Cancer Medication Product Offered

Table 101. GuiZhou YiBai Cancer Medication Revenue ($ million) and YoY Growth, 2019-2021E

Table 102. GuiZhou YiBai Main Business

Table 103. GuiZhou YiBai Latest Developments

Table 104. Lunan Details, Head Office, Cancer Medication Area Served and Its Competitors

Table 105. Lunan Cancer Medication Product Offered

Table 106. Lunan Cancer Medication Revenue ($ million) and YoY Growth, 2019-2021E

Table 107. Lunan Main Business

Table 108. Lunan Latest Developments

Table 109. Eli Lilly and Company Details, Head Office, Cancer Medication Area Served and Its Competitors

Table 110. Eli Lilly and Company Cancer Medication Product Offered

Table 111. Eli Lilly and Company Cancer Medication Revenue ($ million) and YoY Growth, 2019-2021E

Table 112. Eli Lilly and Company Main Business

Table 113. Eli Lilly and Company Latest Developments

List of Figures

Figure 1. Cancer Medication Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Cancer Medication Market Size Growth Rate, 2016-2026 ($ millions)

Figure 6. Cancer Medication Consumption by Region (2016 VS 2021 & 2026) ($ millions)

Figure 7. Global Cancer Medication Market Size Share by Regions, 2016-2026

Figure 8. Americas Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)

Figure 9. APAC Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)

Figure 10. Europe Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)

Figure 11. MENA Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)

Figure 12. Global Cancer Medication Revenue Market Share by Player in 2020

Figure 13. Global Cancer Medication Market Size Share by Type in 2020

Figure 14. Cancer Medication in Blood Cancer

Figure 15. Global Cancer Medication Market Size YoY Growth: Blood Cancer, 2016-2026 ($ millions)

Figure 16. Cancer Medication in Breast Cancer

Figure 17. Global Cancer Medication Market Size YoY Growth: Breast Cancer, 2016-2026 ($ millions)

Figure 18. Cancer Medication in Castrointestinal Cancer

Figure 19. Global Cancer Medication Market Size YoY Growth: Castrointestinal Cancer, 2016-2026 ($ millions)

Figure 20. Cancer Medication in Prostate Cancer

Figure 21. Global Cancer Medication Market Size YoY Growth: Prostate Cancer, 2016-2026 ($ millions)

Figure 22. Cancer Medication in Respiratory/Lung Cancer

Figure 23. Global Cancer Medication Market Size YoY Growth: Respiratory/Lung Cancer, 2016-2026 ($ millions)

Figure 24. Cancer Medication in Other

Figure 25. Global Cancer Medication Market Size YoY Growth: Other, 2016-2026 ($ millions)

Figure 26. Americas Cancer Medication Value Market Share by Country in 2020

Figure 27. Cancer Medication Market Size in United States, 2016-2026 ($ millions)

Figure 28. Canada Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)

Figure 29. Mexico Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)

Figure 30. Brazil Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)

Figure 31. China Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)

Figure 32. Japan Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)

Figure 33. Korea Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)

Figure 34. Taiwan Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)

Figure 35. India Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)

Figure 36. Australia Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)

Figure 37. Indonesia Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)

Figure 38. Thailand Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)

Figure 39. Malaysia Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)

Figure 40. Philippines Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)

Figure 41. Vietnam Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)

Figure 42. Germany Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)

Figure 43. France Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)

Figure 44. UK Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)

Figure 45. Russia Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)

Figure 46. Italy Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)

Figure 47. Australia Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)

Figure 48. Benelux Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)

Figure 49. Nordic Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)

Figure 50. Saudi Arabia Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)

Figure 51. UAE Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)

Figure 52. Turkey Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)

Figure 53. South Africa Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)

Figure 54. Egypt Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)